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1  |  INTRODUC TION
Traditionally, the retina has been considered as the easiest acces-
sible window to study the state of the systemic microcirculation,1 
even if the choroid is the most important vascular layer of the eye, 
which thinning may be due to microvascular damage, reflecting the 
local expression of a more generalized vascular injury.2–4 Recent 
studies have associated changes in the thickness of the choroid with 
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Abstract
Controversy exists about the association of choroidal thickness (CTh) with blood 
pressure (BP) values. There is some evidence suggesting that central hemodynam-
ics changes are associated with microvascular disease. Our study was aimed to as-
sess the relationships between CTh and clinic and 24-h BP and between CTh and 
estimated 24-h aortic pulse pressure (aPP), 24-h aortic systolic BP (aSBP), and 24-h 
aortic augmentation index (aAIx) in a group of hypertensive patients. We enrolled 158 
hypertensive subjects (mean age 48 ± 13 years) all of which underwent evaluation 
of the choroidal district by Swept-Source optical coherence tomography (SS-OCT) 
and 24-h BP monitoring, in order to measure peripheral BP and to estimate central 
hemodynamic parameters. Inverse significant correlations of clinic PP, 24-h aPP, 24-h 
aSBP, and 24-h aAIx with thicknesses of central ring, inner ring, and outer ring of the 
choroid and its overall average were found. The strongest of these correlations was 
that relating 24-h aPP with overall average choroidal thickness (r = −.531; P < .001). 
When we divided the study population in subjects with 24-h aPP above and below 
the median value (35 mm Hg), CTh were thinner in subjects with higher values of 24-
aPP as compared to those with lower ones, even after adjustment for age, and other 
potential confounders. The relationships of CTh with 24-h aPP remained significant 
also taking into account the effects of various covariates in linear multiple regres-
sion analyses. Our findings support the concept of a cross-talk between macro- and 
microcirculation.
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cardiovascular2,3 and renal diseases.4–6 Controversy exists about the 
association of CTh with blood pressure (BP) values.4–10
The pulsatile nature of the central hemodynamics has a dele-
terious impact on vital organs. In a healthy cardiovascular system, 
the elastic properties of the large arteries ensure that pulsations in 
pressure and flow generated by cyclic left ventricular contraction 
are dampened, so that less pulsatile pressure and flow are delivered 
at the microvascular level. However, in response to aging, hyperten-
sion, and other disease states, arterial stiffening limits the buffering 
capacity of the elastic arteries, thus exposing the microvasculature 
to increased pulsatile stress. This is thought to be particularly per-
tinent to high flow/low resistance organs such as the brain and kid-
ney, which may be sensitive to excess pressure and flow pulsatility, 
damaging capillary networks, reinforcing the concept of a cross-talk 
between large and small arteries in hypertension.11–16. There is a 
substantial body of evidence that the aortic pulse pressure predicts 
future cardiovascular and total mortality risk in various patient pop-
ulations.17–19 The aortic pulse pressure is also a better predictive in-
dicator than the brachial pulse pressure,18,19 and clinical studies have 
associated its elevation with the development of macrovascular and 
microvascular damage.
However, little is known about the relationship of choroidal 
thickness (CTh) with peripheral and central measures of pulsatile 
hemodynamics.4,10
The aim of our study was to assess the relationships of CTh with 
clinic and 24-h peripheral BP values and of CTh with estimated mea-
sures of central hemodynamics, derived from 24-h pulse wave anal-
ysis (PWA), in a group of hypertensive patients.
2  |  MATERIAL AND METHODS
The population of this cross-sectional study was selected from 
the Caucasian hypertensive patients consecutively attending the 
Unit of Nephrology and Hypertension and European Society of 
Hypertension (ESH) Excellence center of the University of Palermo, 
between May 2016 and May 2018.
Written informed consent was obtained from all patients, after 
the nature of the study was explained to them. The study protocol 
followed the tenets of the Declaration of Helsinki and was approved 
by the local review board.
The exclusion criteria were:
• Age <20 years and >70 years.
• Known diabetes or fasting glycaemia >126 mg/dl.
• Pregnancy.
• Systemic or ocular diseases (glaucoma, uveitis, high myopia, 
age-related macular degeneration, etc) and/or a history of oph-
thalmic surgery that may have affected the choroidal vascular 
network.
• Nephroparenchymal, renovascular, malignant, or endocrine hy-
pertension or obstructive sleep apnea syndrome.
• Known proteinuria and hematuria.
• Nephritic diseases and hereditary renal diseases.
• Estimated GFR <15 ml/min/1.73 m2.
• Heart failure.
• Positive history or clinical signs of coronary artery disease.
• Positive history or clinical signs of cerebrovascular disease.
• Major non-cardiovascular diseases.
• All those conditions preventing from obtaining reliable auto-
mated BP measurements with the oscillometric technique (eg, 
atrial fibrillation, frequent ectopic beats or second or third-de-
gree atrioventricular blocks, and mid-upper arm circumference 
<22 cm). Patients with an arm circumference larger than 32 cm 
were not excluded from the study, rather an appropriately sized 
cuff was used to obtain accurate BP measurements.
2.1  |  Study design
In all patients, careful clinical history, physical examination, routine 
blood chemistry, urine examination, and 24-hour ambulatory blood 
pressure monitoring (ABPM) were performed. Furthermore, an oph-
thalmologist carried out a complete eye examination.
Patients who reported smoking cigarettes regularly during the 
past year were considered current smokers.
Body weight, height, waist circumference, and office blood pres-
sures were measured by a doctor.
2.2  |  Measurements
Clinic (office) BP was considered as the mean of three consecutive 
measurements obtained at 2-minute intervals by an electronic oscil-
lometric validated20 device (WatchBP Office, Microlife AG, Widnau, 
Switzerland) after 5 min of rest in a sitting position.
A clinically validated and commercially available oscillome-
tric brachial-cuff based BPLab Vasotens device (BPLab GmbH, 
Schwalbach am Taunus)21 was used to perform the 24-h ABPM. 
Current ESH guidelines were followed for proper recording perfor-
mance.22 Briefly, the BP readings were performed automatically at 
15-min intervals during the day and at 20-min intervals during night-
time resting. The time periods were standardized according to the 
time at which the patients rose and retired. The optimal adult cuff 
was wrapped around the nondominant arm, and patients were in-
structed to keep their arm extended and still and to avoid any move-
ment during each automatic BP measurement. They were free to 
attend their usual daily activities during ABPM (avoiding strenuous 
exercise).
After fitting the device, patients were sent home and asked to 
resume normal life and to come back 24 h later for removal of the 
instrumentation.
The oscillometric BPLab device also allows measurements of 
ambulatory central hemodynamics by recording pulsatile pressure 
changes at the brachial artery level.
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The ABPM waveforms were analyzed using BPLab Vasotens® 
technology (Petr Telegin), which allows calculation of central pulse 
wave parameters from the peripheral pulse wave. In measuring BP, 
the pressure pulsations in the cuff are registered during a step-by-
step deflation. The sampling rate of the device is 100 Hz. After dig-
italization, the signal processing is performed using a proprietary 
mathematical algorithm, which is based on a generalized transfer 
function that uses a modification of a certain frequency range. The 
amplitude of all signals recorded when the pressure in the cuff ex-
ceeded the systolic BP was used for waveform averaging.23
The accuracy of the BPLab device for the assessment of vascu-
lar indices has been validated in studies against a non-invasive gold 
standard.23,24
A detailed description of the methodology may be found 
elsewhere.23–25
Routine biochemical parameter determination was performed 
with standard techniques using an autoanalyzer. Low-density lipo-
protein cholesterol was calculated by the Friedewald formula.
Estimated GFR (eGFR) was calculated using the Chronic Kidney 
Disease Epidemiology Collaboration (CKD-EPI) equation.26
Ophthalmologists, not aware of clinical and biohumoral data 
of the patient, performed in all patients a complete eye examina-
tion, including the best corrected visual acuity with Early Treatment 
Diabetic Retinopathy Study (ETDRS) charts, intraocular pressure 
measurement, anterior segment, and dilated fundus evaluation.
The choroidal district was evaluated morphologically by Swept-
Source (SS) optical coherence tomography (OCT) (DRI Triton, Topcon 
Inc, Japan), always in the morning, during the same temporal interval 
(10-12 AM). All scans were performed by a single operator. The right 
eye was examined first. A standardized protocol was followed for all 
scans, as previously described.5,6,27 Poor quality scans were rejected 
or repeated.
The scans were then read and analyzed by two specialized 
ophthalmologists.
Because not significant differences were noted between the two 
eyes, only one eye of each subject was randomly selected for anal-
ysis, by using a random number generator. If the image quality of 
the selected eye was deemed insufficient, the contralateral eye was 
chosen for analyses.
2.3  |  Quantitative analysis
The choroidal thickness (from the outer surface of the RPE, to the 
choroidal scleral interface, CSI) was automatically calculated by the 
OCT mapping software. OCT measurements were performed ac-
cording to the ETDRS protocol.28 The ETDRS map divides the mac-
ula into 9 subfields. The circular grid is centered over the fovea and 
consists of 3 concentric rings of diameters 1, 3, and 6 mm, respec-
tively. The inner and outer rings are further divided into quadrants: 
temporal, nasal, superior, and inferior (Figure 1).
Measurements were performed for each of the nine regions of 
the ETDRS grid, for both the retina and the choroid. Furthermore, 
we calculated the average of the individuals values of the four quad-
rants separately for the inner and the outer ring. The average of all 
the nine regions of the ETRDS grid (including the inner, the outer, 
and the central rings) was also calculated.
2.4  |  Statistical analysis
Normal distribution of the continuous variables was assessed 
using the Kolmogorov–Smirnov test, and the assumption of sat-
isfactory Gaussian distribution was met for all of the examined 
parameters, except for serum triglycerides, and for aortic aug-
mentation index (aAix) which showed a positively skewed distri-
bution. This variable was given as median and interquartile range 
(IQR) and mathematically transformed to better satisfy distribu-
tional assumptions before parametric tests were used. All the 
other normal distributed continuous variables were expressed as 
mean ± standard deviation.
Categorical variables were expressed as percentage values.
The overall study population was divided in two groups based on 
the median value (35 mmHg) of 24-h aortic pulse pressure.
F I G U R E  1  The chorioretinal structures en face (left images) and as a cross-section (right images). The Early Treatment Diabetic 
Retinopathy Study map divides the macula into 9 subfields. A circular grid is centered over the fovea and consists of 3 concentric rings of 
diameters 1, 3, and 6 mm, respectively. The inner and outer rings are further divided into quadrants: temporal, nasal, superior, and inferior
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Differences between groups were evaluated using the indepen-
dent-sample Student t test for continuous variables and the χ2 test, 
with the Yates correction (or Fisher exact test when appropriate), for 
the categorical variables. Adjustment for age, estimated GFR, (Log) 
triglycerides, serum glucose, and HDL cholesterol (Figure 2) was car-
ried out by analysis of covariance.
Simple regression analyses and Pearson correlation coefficients 
were used to test the relationships between choroidal measures 
and the other variables. In order to assess the independent relation-
ships between the examined variables, stepwise multiple regression 
models were built considering initially each choroidal parameter as 
outcome variable and 24-h peripheral or central pulse pressure, sep-
arately from each other, as regressors, along with age, sex, smoking 
habit, antihypertensive therapy (yes/no), mean 24-h (or clinic) blood 
pressure, serum glucose, eGFR, HDL cholesterol, (log) triglycerides. 
Subsequently, we built other multivariate models in which 24-h bra-
chial PP, or clinic PP, or 24-h central or peripheral systolic BP, or 24-h 
aortic augmentation index were forced, separately from each other, 
into the same previous multivariate models including also 24-h aor-
tic PP.
In all multiple regression analyses, a backward stepwise proce-
dure was used, with α = 0.15 as the cutoff for entry or removal of 
variables. Collinearity was assessed by calculating the variance in-
flation factor (VIF): Variables with VIF ≥ 2 were excluded from the 
models.
The null hypothesis was rejected at a two-tailed P < .05.
The statistical analyses were performed using the IBM SPSS 
Statistics software package, version 22 for Macintosh (SPSS).
3  |  RESULTS
A total of 155 subjects were included in this analysis. Table 1 gives 
the general characteristics of the overall study population and of the 
two groups divided on the basis of a 24-h aPP above or below the 
median value, that is 35 mmHg.
The group of patients with 24-h aortic PP > 35 m/s were older 
and had lower estimated GFR values when compared to the coun-
terparts with 24-h aortic PP ≤ 35 m/s. Sixty-six percent of patients 
were pharmacologically treated for hypertension. The distribution 
of these subjects was not significantly different between the two 
groups and only a slightly greater percentage of subjects treated 
with centrally acting antiadrenergic drugs and allopurinol was ob-
served in the group with highest 24-h aortic PP (Table S1).
The patients treated with antihypertensive medications were 
older (P < .001), had lower estimated GFR values (P = .004), and thin-
ner thicknesses of the inner (P = .02) and outer (P = .03) choroidal 
rings. These two latter differences lost statistical significance after 
adjustment for age (both P > .44).
Clinic, 24-h brachial and central PP, 24-h peripheral and central 
systolic BP were higher and 24-h aortic diastolic BP and mean BP 
were lower in the groups with greater values of ambulatory aortic 
PP when compared to the counterparts with lower ones (Table 2). All 
the CTh measurements examined were thinner in the subjects with 
higher 24-h aortic PP than in those with lower aPP (Table 3). The dif-
ferences regarding CTh thicknesses remained significant even after 
adjustment, by ANCOVA for age, estimated GFR, (Log) Triglycerides, 
Serum glucose and HDL cholesterol (Figure 2).
Close correlations of all the assessed CTh measures with mea-
sures of central hemodynamics were found (Table S2). Particularly 
strong was the correlation of 24-h aPP with CTh average overall 
ring that is shown in Figure 3, where the regression line and the re-
gression equation are also reported. The independent associations 
of 24 h aortic PP with CTh measurements were confirmed in var-
ious multiple stepwise linear regression models (Table 4), in which 
CTh measurements were included, separately from each other, as 
outcome variables and 24 h aortic PP were regarded as indepen-
dent variables, along with age, sex, smoking habit, antihypertensive 
therapy (yes/no), mean 24-h aortic BP, serum glucose, eGFR, HDL 
cholesterol, (log) triglycerides. When in the same multiple regression 
models, 24 h aortic PP was replaced by 24 h brachial PP, also this 
hemodynamic parameter showed a significant, but less strong, as-
sociation with choroidal thickness. However, when 24-h brachial PP, 
or clinic PP, or 24 h central or peripheral systolic BP, or 24-h aortic 
augmentation index were forced, separately from each other, into 
the same previous multivariate models including also 24 h aortic 
PP, only this latter remained significantly associated with choroidal 
thicknesses.
4  |  DISCUSSION
Alterations in microvascular structure and function contribute to 
the development and progression of hypertension, diabetes, CKD, 
F I G U R E  2  Differences in choroidal thicknesses between 
hypertensive subjects with 24-h aortic estimated aortic pulse 
pressure (aPP) PWV above and below the median value (35 mmHg). 
The values are given as the mean ± SEM and are adjusted, by 
ANCOVA, for age, estimated GFR, (Log) triglycerides, serum 
glucose and HDL cholesterol
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TA B L E  1  Demographic, anthropometric and clinical characteristics of the whole population and of the groups divided on the basis of the 
median value (35 mmHg) of 24 h aortic pulse pressures (aPP)
Overall study population 
(n = 158)
Subjects with 24-h aPP
≤35 mmHg (n = 77)
Subjects with 24-h aPP
>35 mmHg (n = 81) p
Age (years) 47.7 ± 12.8 44.9 ± 11.0 50.3 ± 13.7 .01
Sex, Males (%) 72.2 74.0 70.4 .61
Smokers (%) 22.8 24.7 21.0 .37
Patients treated with antihypertensive 
drugs (%)
66.5 64.9 67.9 .69
Body mass index (kg/m2) 27.8 ± 4.3 27.8 ± 4.4 28.02 ± 4.3 .73
Waist circumference (cm) 96.1 ± 11.6 95.4 ± 12.2 96.7 ± 10.9 .49
Estimated GFR (ml/min/1.73 m2) 85.5 ± 24.2 89.6 ± 20.7 81.5 ± 26.7 .03
Total cholesterol (mg/dl) 192.3 ± 30.0 195.1 ± 28.8 195.1 ± 32.1 .27
HDL cholesterol (mg/dl) 50.0 ± 12.9 48.8 ± 11.8 51.2 ± 13.9 .24
Serum Triglycerides (mg/dl) 108.7 (81.6-144.3) 109.2 (78.8-143) 106.2 (81.5-145) .99
LDL cholesterol (mg/dl) 118.7 ± 29.0 122.7 ± 27.8 114.9 ± 29.8 .09
Serum glucose (mg/dl) 95.4 ± 14.8 94.9 ± 16.2 96.0 ± 13.4 .63
TA B L E  2  Main hemodynamic data of the overall population and of the groups with 24-h aPP above and below 35 mmHg
Overall study population 
(n = 158)
Subjects with 24-h aPP
≤35 mmHg (n = 77)
Subjects with 24-h aPP
>35 mmHg (n = 81) p
Peripheral parameters
Clinic systolic BP (mmHg) 139 ± 13.5 137 ± 12.0 141 ± 14.5 .09
Clinic diastolic BP(mmHg) 86 ± 9.5 87 ± 9.7 85 ± 9.2 .26
Clinic pulse pressure (mmHg) 53 ± 10.9 50 ± 9.8 56 ± 11.3 <.001
Clinic mean BP (mmHg) 104 ± 9.7 104 ± 9.5 104 ± 9.9 .95
Clinic heart rate (bpm) 73 ± 10.9 74 ± 10.9 73 ± 10.9 .7
24-h systolic BP (mmHg) 130 ± 12.9 127 ± 11.7 133 ± 13.5 <.001
24-h diastolic BP (mmHg) 82 ± 8.9 84 ± 8.3 80 ± 9.4 .004
24-h pulse pressure (mmHg) 47 ± 10.4 43 ± 8.5 53 ± 11.4 <.001
24-h mean BP (mmHg) 98 ± 9.2 98 ± 8.1 98 ± 10.3 .99
24-h heart rate (bpm) 72 ± 10.5 72 ± 11.3 72 ± 9.7 .99
Central measures
24-h aortic systolic BP (mmHg) 120 ± 12.6 113 ± 11.0 127 ± 12.8 <.001
24-h aortic diastolic BP (mmHg) 83 ± 13.6 85 ± 10.6 79 ± 13.8 .003
24-h aortic pulse pressure 
(mmHg)
37 ± 13.6 28 ± 5.0 48 ± 10 <.001
24-h aortic mean BP (mmHg) 95 ± 12 94 ± 12.7 95 ± 10.8 .594
24-h aortic augmentation index 
(%)
11.84 (2-22.4) 2.3 (−3.03-8.90) 21 (12.4-29.8) <.001
TA B L E  3  Choroidal thickness measurements of the overall population and in the groups with 24h aPP above and below 35 mmHg
Overall study population 
(n = 158)
Subjects with 24 h aPP
≤35 mmHg (n = 77)
Subjects with 24 h aPP
>35 mmHg (n = 81) p
Choroidal thickness (μm)
Average overall ring 250.4 ± 62.0 278.9 ± 51.2 223.5 ± 59.5 <.001
Central ring 263.2 ± 73.2 297.2 ± 61.6 230.9 ± 68.9 <.001
Inner ring 251.9 ± 65.6 278.1 ± 59.8 227.4 ± 61.5 <.001
Outer ring 235.9 ± 59.15 260.6 ± 48.2 212.6 ± 59.4 <.001
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and CV diseases.29,30 Notably, such changes precede the develop-
ment of end-organ damage and appear modifiable. The use of reti-
nal examination as a method to evaluate microcirculation has been 
traditionally proposed due to its unique capability to view easily the 
vasculature of the posterior segment in vivo and in a non-invasive 
manner, thus providing a snapshot of vascular health.1 However, the 
choroid is the most vascularized layer of the eye with a very high 
perfusion rate. Per unit weight, the choroid has the highest blood 
flow of any tissue in the body,31 even greater than that of the brain 
and the kidney. These latter organs are continually perfused at high 
volume flow throughout systole and diastole so that pulsations are 
transmitted through the capillary network up to the venous efflux. 
Such fluctuations, measurable as central pulse pressure, increase 
if the elastic properties of the aorta are impaired. Indeed, aortic 
stiffness increases the delivery of pulsatile energy into the micro-
circulation, especially in those vascular districts more vulnerable 
for their low impedance. Exposure of renal and cerebral small ves-
sels to highly pulsatile pressure and flow can lead to constriction 
of resistance vessels and subsequently to structural damage.11–16 
The chorioretinal microcirculation shares similar embryological ori-
gin, anatomic features, and physiological properties with renal and 
cerebral microvasculature.32 It is therefore conceivable that the 
choroid may be exposed, and damaged by increased flow pulsatil-
ity like the brain and the kidney. The results of our study, showing 
that choroidal thickness is reduced in hypertensive patients with 
increased indices of pulsatile hemodynamics, seem to support this 
hypothesis and are in agreement with a mounting evidence sug-
gesting that choroidal thickness changes may be a non-invasive 
biomarker of CV damage.2–4,31 Indeed, we found a close inverse 
association of the thickness of various regions of the choroid, as 
well as of its overall thickness, with increased aortic augmentation 
index and with elevated clinic and 24-h peripheral PP and above all 
with central PP.
It is reasonable that morphological alterations of the choroid 
could represent the local epiphenomenon of a systemic vascular in-
jury not less than the retinal ones, and the evidence that choroid 
may be directly damaged by acute and chronic severe elevation of 
BP seems to confirm this hypothesis.31,33
The structural evaluation of the choroid in vivo was for a long 
time limited by its deep location. The introduction in last years of 
advanced techniques of OCT, providing high-resolution, cross-sec-
tional imaging of the eye with near histological detail, has greatly 
increased our understanding of the choroid.34 This allowed us to 
recognize that alterations of its microvasculature can be indicative 
of systemic diseases that affect blood vessels of both the macro- 
and microcirculation.2,33 In particular, in recent years it has been 
F I G U R E  3  Scattergram showing the negative relationship 
between 24-h aortic pulse pressure and the average global 
choroidal thickness in men (dark squares) and women (gray circles) 
of the overall study population. The calculated regression line is 
also shown. Broken hyperbolic lines represent the 95% confidence 
bands around the regression line
TA B L E  4  Standardized multiple regression coefficients (β) relating 24-h aortic pulse pressure (A), or 24-h brachial pulse pressure (B) with 
choroidal thickness, calculated after adjustment for various potential confounding factors. Only variables that entered the final model are 
reported. See text for further explanations
(A) Outcome 
variables CTh central ring (R2: .337) CTh inner ring (R2: .306) CTh outer ring (R2: .352)
CTh average overall ring 
(R2: .378)
Independent 
variables β p β p β p β p
24-h aortic pulse 
pressure
−0.452 <.001 −0.38 <.001 −0.413 <.001 −0.441 <.001
Age −0.260 <.001 −0.321 <.001 −0.336 <.001 −0.324 <.001
(B) Outcome variables CTh central ring (R2: .206) CTh inner ring (R2: .237) CTh outer ring (R2: .262)
CTh average overall 
ring (R2: .260)
Independent variables β p β p β p β p
24-h brachial pulse 
pressure
−0.244 .001 −0.243 .001 −0.247 .001 −0.252 <.001
Age −0.336 <.001 −0.376 <.001 −0.401 <.001 −0.395 <.001
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observed that changes in the thickness of the choroid are associated 
with CVaand renal abnormalities.4–6,27
The independent prognostic value of vascular biomarkers ob-
tained through pulse wave analysis (PWA), such as central BP, and 
augmentation index (AIx), in resting conditions, has been docu-
mented in a variety of patient groups and populations, even if more 
evidence is needed before recommending their routine clinical 
use.11,13
The most widely adopted methods for evaluating pulse wave-
forms are those based on applanation tonometry and transfer 
functions.11,13 In last years, instruments, using an oscillometric tech-
nique, and a procedure that takes only 2-3 min, allow estimation of 
aortic PWA indices by using a simple upper arm cuff.23,24 Some of 
these devices, like that used in our study, have versions developed 
for 24-h BP and 24 h PWA monitoring23,24 and provide PWA val-
ues very close to those recorded by widely accepted and clinically 
validated devices.24 Such techniques are affordable and have made 
the assessment largely operator-independent and allowed to extend 
the evaluation of arterial functional state to ambulatory conditions. 
These new methods may provide an opportunity for the spread of 
central PWA measurements and to further refine the CV risk stratifi-
cation. As it is well known that organ damage is more closely related 
to ambulatory than to office BP, routine measurements of ambu-
latory central hemodynamics may have some potential for a more 
affordable and detailed assessment of vascular health in daily-life 
conditions.
Our findings seem also to corroborate the concept of a cross-
talk between macro- and microcirculation,12 that is also supported 
by many evidences of an association of measures of central hemody-
namics with microvascular changes in the heart,12 the kidney,4,5 the 
brain,13 and the retina.12
Our results are also in agreement with the study of Balmforth 
and colleagues,4 that in a subgroup of 20 nondiabetic subjects with 
chronic kidney diseases found inverse significant correlations be-
tween CTh and aortic stiffness, measured by a tonometric method. 
Remarkably, in the same investigation significant relationships were 
found of choroidal thinning with endothelin-1, asymmetric dimeth-
ylarginine and interleukin-6 serum levels,4 all markers of endothelial 
dysfunction and vascular inflammation, that are also closely linked 
to aortic stiffness.
It is important to note that, with the exception of 24 h cen-
tral systolic BP, pulse pressure was the only BP component in-
dependently related to CTh. Regarding the association of blood 
pressures with CTh, previous studies yielded conflicting results. 
In the above-mentioned study of Balmforth and colleagues,4 no 
relationship was detected between systolic and diastolic BP and 
chorioretinal thicknesses, and the latter were not different when 
comparing hypertensive subjects to normotensive controls.4 
Contrariwise, Akay and colleagues7 and Masis and colleagues8 
reported that the choroid was thinner in hypertensive patients 
compared to nonhypertensive ones. It is noteworthy that in both 
these investigations important confounding factors such as renal 
function were not taken into account. More recently, Gök and col-
leagues,9 in 116 hypertensive patients who underwent 24-h ABPM 
and OCT, did not find any significant relationship of choroidal 
thickness with the average of BP readings recorded over 24 h. In 
contrast, weak correlations between BP and CTh were observed in 
the study of Dagel and colleagues,10 but no multivariate analyses 
were performed. However, in none of these studies information 
about pulse pressure were provided.
The relationships that we found between CTh measures and 
aortic PP were independent of many potential confounding factors, 
such as particularly age and estimated GFR that in our previous stud-
ies were the strongest correlates of CTh.5,6 It was also independent 
of serum glucose that, even if diabetic patients were not included in 
our study, disclosed a negative correlation with CTh.
The cross-sectional design of our study precludes conclusions 
regarding temporal causal relationships between CTh and aor-
tic PP. Among the hypotheses that may be formulated, the most 
reasonable seems to be that previously discussed, that CTh thin-
ning may be caused by the excessive pulsatile barotrauma due to 
increased vascular stiffness, that limits the buffering capacity of 
elastic arteries. On the other hands, we cannot exclude the possi-
bility that CTh thinning and changes in central hemodynamics are 
not causally related, but both may be the consequence of com-
mon factors able to exert their detrimental effects independently 
on the micro- and macrocirculation. Moreover, CTh thinning may 
be the marker of a more generalized microcirculation rarefaction. 
This may increase peripheral resistances, leading to a greater mag-
nitude of wave reflection and therefore to a worsening of central 
hemodynamics.
In conclusion, our study, by using an innovative imaging tech-
nique such as SS-OCT, documented a significant association be-
tween increased pulsatile hemodynamics, a well-known index of 
early vascular aging and predictor of CV risk, and reduction of cho-
roidal thickness in patients with primary hypertension.
Our findings support the concept of a cross-talk between macro- 
and microcirculation.
Further studies, with a different experimental design, are needed 
to explain the pathophysiological reasons of our results and to un-
derstand whether the information obtained about choroidal thick-
ness with SS-OCT may have cardiovascular prognostic implications 
and clinical usefulness.
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